These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8176574)

  • 1. Orally administered clarithromycin for the treatment of systemic Mycobacterium avium complex infection in children with acquired immunodeficiency syndrome.
    Husson RN; Ross LA; Sandelli S; Inderlied CB; Venzon D; Lewis LL; Woods L; Conville PS; Witebsky FG; Pizzo PA
    J Pediatr; 1994 May; 124(5 Pt 1):807-14. PubMed ID: 8176574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome.
    Pierce M; Crampton S; Henry D; Heifets L; LaMarca A; Montecalvo M; Wormser GP; Jablonowski H; Jemsek J; Cynamon M; Yangco BG; Notario G; Craft JC
    N Engl J Med; 1996 Aug; 335(6):384-91. PubMed ID: 8663871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective randomized trial of four three-drug regimens in the treatment of disseminated Mycobacterium avium complex disease in AIDS patients: excess mortality associated with high-dose clarithromycin. Terry Beirn Community Programs for Clinical Research on AIDS.
    Cohn DL; Fisher EJ; Peng GT; Hodges JS; Chesnut J; Child CC; Franchino B; Gibert CL; El-Sadr W; Hafner R; Korvick J; Ropka M; Heifets L; Clotfelter J; Munroe D; Horsburgh CR
    Clin Infect Dis; 1999 Jul; 29(1):125-33. PubMed ID: 10433575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of clarithromycin-sensitive and clarithromycin-resistant Mycobacterium avium strains isolated from AIDS patients during therapy regimens including clarithromycin.
    Matsiota-Bernard P; Zinzendorf N; Onody C; Guenounou M
    J Infect; 2000 Jan; 40(1):49-54. PubMed ID: 10762111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does in vitro susceptibility to rifabutin and ethambutol predict the response to treatment of Mycobacterium avium complex bacteremia with rifabutin, ethambutol, and clarithromycin? Canadian HIV Trials Network Protocol 010 Study Group.
    Shafran SD; Talbot JA; Chomyc S; Davison E; Singer J; Phillips P; Salit I; Walmsley SL; Fong IW; Gill MJ; Rachlis AR; Lalonde RG
    Clin Infect Dis; 1998 Dec; 27(6):1401-5. PubMed ID: 9868650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clarithromycin or rifabutin alone or in combination for primary prophylaxis of Mycobacterium avium complex disease in patients with AIDS: A randomized, double-blind, placebo-controlled trial. The AIDS Clinical Trials Group 196/Terry Beirn Community Programs for Clinical Research on AIDS 009 Protocol Team.
    Benson CA; Williams PL; Cohn DL; Becker S; Hojczyk P; Nevin T; Korvick JA; Heifets L; Child CC; Lederman MM; Reichman RC; Powderly WG; Notario GF; Wynne BA; Hafner R
    J Infect Dis; 2000 Apr; 181(4):1289-97. PubMed ID: 10762562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group.
    Shafran SD; Singer J; Zarowny DP; Phillips P; Salit I; Walmsley SL; Fong IW; Gill MJ; Rachlis AR; Lalonde RG; Fanning MM; Tsoukas CM
    N Engl J Med; 1996 Aug; 335(6):377-83. PubMed ID: 8676931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clarithromycin. A review of its pharmacological properties and therapeutic use in Mycobacterium avium-intracellulare complex infection in patients with acquired immune deficiency syndrome.
    Barradell LB; Plosker GL; McTavish D
    Drugs; 1993 Aug; 46(2):289-312. PubMed ID: 7691518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. A randomized, double-blind, dose-ranging study in patients with AIDS. AIDS Clinical Trials Group Protocol 157 Study Team.
    Chaisson RE; Benson CA; Dube MP; Heifets LB; Korvick JA; Elkin S; Smith T; Craft JC; Sattler FR
    Ann Intern Med; 1994 Dec; 121(12):905-11. PubMed ID: 7978715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind trial comparing azithromycin and clarithromycin in the treatment of disseminated Mycobacterium avium infection in patients with human immunodeficiency virus.
    Dunne M; Fessel J; Kumar P; Dickenson G; Keiser P; Boulos M; Mogyros M; White AC; Cahn P; O'Connor M; Lewi D; Green S; Tilles J; Hicks C; Bissett J; Schneider MM; Benner R
    Clin Infect Dis; 2000 Nov; 31(5):1245-52. PubMed ID: 11073759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of the macrolide clarithromycin in the treatment of Mycobacterium avium complex infection in HIV-infected patients.
    Ruf B; Schürmann D; Mauch H; Jautzke G; Fehrenbach FJ; Pohle HD
    Infection; 1992; 20(5):267-72. PubMed ID: 1428183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, open-label trial of azithromycin plus ethambutol vs. clarithromycin plus ethambutol as therapy for Mycobacterium avium complex bacteremia in patients with human immunodeficiency virus infection. Veterans Affairs HIV Research Consortium.
    Ward TT; Rimland D; Kauffman C; Huycke M; Evans TG; Heifets L
    Clin Infect Dis; 1998 Nov; 27(5):1278-85. PubMed ID: 9827282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clarithromycin resistance and susceptibility patterns of Mycobacterium avium strains isolated during prophylaxis for disseminated infection in patients with AIDS.
    Craft JC; Notario GF; Grosset JH; Heifets LB
    Clin Infect Dis; 1998 Oct; 27(4):807-12. PubMed ID: 9798037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment with clarithromycin of 173 HIV+ patients with disseminated Mycobacterium avium intracellulare infection].
    Dautzenberg B; Saint-Marc T; Durant J; Reynes J; Meyohas MC; Legrand MF; Truffot C; Chauvin JP
    Rev Mal Respir; 1994; 11(3):271-6. PubMed ID: 8041990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clarithromycin-induced mania in two patients with AIDS.
    Nightingale SD; Koster FT; Mertz GJ; Loss SD
    Clin Infect Dis; 1995 Jun; 20(6):1563-4. PubMed ID: 7548513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful short-term suppression of clarithromycin-resistant Mycobacterium avium complex bacteremia in AIDS. California Collaborative Treatment Group.
    Dubé MP; Torriani FJ; See D; Havlir DV; Kemper CA; Leedom JM; Tilles JG; McCutchan JA; Sattler FR
    Clin Infect Dis; 1999 Jan; 28(1):136-8. PubMed ID: 10028084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome. A controlled clinical trial.
    Dautzenberg B; Truffot C; Legris S; Meyohas MC; Berlie HC; Mercat A; Chevret S; Grosset J
    Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):564-9. PubMed ID: 1832527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clarithromycin prophylaxis for disseminated Mycobacterium avium complex infection--efficacy and acquired resistance.
    Shafran SD
    Clin Infect Dis; 1998 Oct; 27(4):813-5. PubMed ID: 9798038
    [No Abstract]   [Full Text] [Related]  

  • 19. Clarithromycin against Mycobacterium avium complex infections.
    Heifets LB
    Tuber Lung Dis; 1996 Feb; 77(1):19-26. PubMed ID: 8733409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycobacterium avium complex infection. Pharmacokinetic and pharmacodynamic considerations that may improve clinical outcomes.
    Peloquin CA
    Clin Pharmacokinet; 1997 Feb; 32(2):132-44. PubMed ID: 9068928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.